carbamates has been researched along with yo-pro 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianchi, BR; Cavanaugh, EJ; Chen, J; Faltynek, CR; Kim, D; Kym, PR; Reilly, RM | 1 |
| Banke, TG; Chaplan, SR; Wickenden, AD | 1 |
2 other study(ies) available for carbamates and yo-pro 1
| Article | Year |
|---|---|
Pore dilation occurs in TRPA1 but not in TRPM8 channels.
Topics: Aldehydes; Allyl Compounds; Anesthetics, Local; Animals; Benzamides; Benzoxazoles; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Carbamates; Cells, Cultured; HeLa Cells; Humans; Ion Channel Gating; Lidocaine; Membrane Potentials; Movement; Nerve Tissue Proteins; Porins; Quinolinium Compounds; Rats; Thiocyanates; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPM Cation Channels | 2009 |
Dynamic changes in the TRPA1 selectivity filter lead to progressive but reversible pore dilation.
Topics: Animals; Benzamides; Benzoxazoles; Calcium; Calcium Channels; Carbamates; Cell Membrane; Cell Membrane Permeability; CHO Cells; Cricetinae; Cricetulus; Dogs; Dose-Response Relationship, Drug; Farnesol; Humans; Ion Channel Gating; Isothiocyanates; Kinetics; Meglumine; Membrane Transport Modulators; Nerve Tissue Proteins; Purinergic P2 Receptor Agonists; Quinolinium Compounds; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Salicylates; Transfection; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPM Cation Channels; TRPV Cation Channels | 2010 |